信隆健康
(002105)
| 流通市值：17.86亿 | | | 总市值：17.95亿 |
| 流通股本：3.64亿 | | | 总股本：3.66亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,073,497,217.55 | 717,097,027.34 | 359,564,905.91 | 1,187,687,703.11 |
| 营业收入 | 1,073,497,217.55 | 717,097,027.34 | 359,564,905.91 | 1,187,687,703.11 |
| 二、营业总成本 | 1,090,917,168.89 | 725,270,304.61 | 360,133,901.34 | 1,218,348,833.32 |
| 营业成本 | 939,933,053.96 | 624,048,372.3 | 312,321,001.81 | 1,038,827,229.55 |
| 税金及附加 | 7,621,702 | 5,470,554.03 | 2,924,591.12 | 9,251,550.43 |
| 销售费用 | 29,847,859.28 | 19,620,973.98 | 8,836,748.79 | 40,170,864.59 |
| 管理费用 | 59,924,723.69 | 38,932,346.92 | 17,992,649.68 | 78,444,602.09 |
| 研发费用 | 32,028,813.83 | 20,657,874.76 | 9,848,134.28 | 41,896,323.01 |
| 财务费用 | 21,561,016.13 | 16,540,182.62 | 8,210,775.66 | 9,758,263.65 |
| 其中:利息费用 | 11,534,915.77 | 8,040,738.14 | 3,979,753.78 | 20,675,894.97 |
| 其中:利息收入 | 3,871,850.23 | 2,368,122.24 | 1,183,304.99 | 9,914,572.87 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | -4,345,701.07 | -3,631,921.46 | -948,063.19 | -3,973,855.94 |
| 资产处置收益 | -124,445.19 | -474,814.71 | -44,395.4 | 34,776.61 |
| 资产减值损失(新) | -2,222,697.86 | -2,102,022.57 | - | -33,850,909.56 |
| 信用减值损失(新) | 211,054.76 | 777,432.29 | - | -6,612,766.05 |
| 其他收益 | 1,190,845.63 | 849,190.09 | 437,414.81 | 1,955,433.43 |
| 四、营业利润 | -22,710,895.07 | -12,755,413.63 | -1,124,039.21 | -73,108,451.72 |
| 加:营业外收入 | 23,155,946.59 | 22,806,071.17 | 68,737.13 | 9,622,978.87 |
| 减:营业外支出 | 2,372,190.25 | 1,134,835.56 | 502,497.54 | 3,737,480.49 |
| 五、利润总额 | -1,927,138.73 | 8,915,821.98 | -1,557,799.62 | -67,222,953.34 |
| 减:所得税费用 | 3,160,183.07 | 2,179,848.61 | 396,037.17 | 670,568.33 |
| 六、净利润 | -5,087,321.8 | 6,735,973.37 | -1,953,836.79 | -67,893,521.67 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -5,087,321.8 | 6,735,973.37 | -1,953,836.79 | -67,893,521.67 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -2,411,671.4 | 8,034,466.84 | -1,943,906.19 | -64,114,657.08 |
| 少数股东损益 | -2,675,650.4 | -1,298,493.47 | -9,930.6 | -3,778,864.59 |
| 扣除非经常损益后的净利润 | -24,105,613.69 | -13,654,694.18 | -1,885,492.19 | -71,780,175.57 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.01 | 0.02 | -0.01 | -0.17 |
| (二)稀释每股收益 | -0.01 | 0.02 | -0.01 | -0.17 |
| 八、其他综合收益 | -7,124,065.66 | -6,583,998.71 | -5,803,445.63 | -6,399,028.37 |
| 归属于母公司股东的其他综合收益 | -4,750,060.42 | -4,411,689.77 | -3,916,719.37 | -4,289,139.22 |
| 九、综合收益总额 | -12,211,387.46 | 151,974.66 | -7,757,282.42 | -74,292,550.04 |
| 归属于母公司股东的综合收益总额 | -7,161,731.82 | 3,622,777.07 | -5,860,625.56 | -68,403,796.3 |
| 归属于少数股东的综合收益总额 | -5,049,655.64 | -3,470,802.41 | -1,896,656.86 | -5,888,753.74 |
| 公告日期 | 2026-10-24 | 2026-08-22 | 2026-04-29 | 2026-04-24 |
| 审计意见(境内) | | | | 标准无保留意见 |